Case Studies
TheraSkin is clinically effective in healing recalcitrant, chronic wounds. These case studies have shown
TheraSkin Case Study #3:
Diabetic patient with Wagner 2/3 foot ulcer. Wound treated for seven weeks with minimal progress. Initial diabetic wound has deep fibrous tissues exposed. Negative Pressure Wound Therapy is used with TheraGauze® as the wound interface to promote vascular tissue. TheraSkin® is applied after two weeks of NPWT, and covered with TheraGauze®. Incorporation of TheraSkin® is evident after just five days. TheraGauze® continues to be used as cover dressing with NPWT. Wound closes at week 19 at a rate of 1.8 cm2 per week, with a single TheraSkin® application and TheraGauze® as the wound cover dressing.
TheraSkin DFU Case Study #4:
TheraSkin VLU Case Study #5:
TheraSkin VLU Case Study #6:
TheraSkin DFU Case Study #7:
TheraSkin Stomach Wound Case Study #8:
Case Studies are ongoing throughout the country. If you are interested in participating in a TheraSkin® evaluation, please contact Soluble Systems Customer Service toll-free at 1-877-222-2681.
- Biologically active cryopreserved real human skin allograft
- Epidermis and dermis layers
- Fully developed extracellular matrix (ECM)
- Promotes growth factors, cytokines and human collagen to the wound
- Living cells
- Promotes granulation and epithelialization
- Jumpstarts wound healing